Xiaojuan Yu

机构：Ministry of Education of the People's Republic of China, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, National Medical Products Administration, Ministry of Education, Ministry of Education, Peking University People's Hospital, Peking University First Hospital, National Institutes for Food and Drug Control · ORCID：0000-0002-6017-7188

发表论文 102 篇 · 总被引 756 次 · h-index 16

代表论文

• Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study (2025 · The Lancet · 被引 41)
• Improving Kidney Outcomes in Patients With Nondiabetic Chronic Kidney Disease Through an Artificial Intelligence–Based Health Coaching Mobile App: Retrospective Cohort Study (2023 · JMIR mhealth and uhealth · 被引 24)
• Clinicopathological Features of Kidney Injury Related to Immune Checkpoint Inhibitors: A Systematic Review (2023 · Journal of Clinical Medicine · 被引 21)
• Characteristics of Complement Protein Deposition in Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposition (2023 · Clinical Journal of the American Society of Nephrology · 被引 10)
• Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy (2024 · Renal Failure · 被引 7)
• Lessons for the clinical nephrologist: a rare case with MGRS characterized by combined crystalline light chain proximal tubulopathy and crystal-storing histiocytosis responding to daratumumab (2023 · Journal of Nephrology · 被引 7)